When a drug called Remdesivir showed promising signs in preliminary COVID-19 trials, the US allowed it to be used in hospitals. But around the globe, access to this new drug has been extremely difficult. In fact, it’s unclear whether huge parts of Latin America, especially, hit hard by COVID-19, will have a way to get it at all. The World’s Elana Gordon reports.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?